Risk for Suicidal Behavior Among Psoriasis Patients: A Nationwide Cohort Study
The link between psoriasis and suicidality remains elusive and understudied.
The aim was to assess the risk of suicidal behavior in psoriasis patients.
We used Taiwan’s National Health Insurance Research Database to conduct a nationwide retrospective cohort study to examine the risk for suicidal behavior among psoriasis patients. We performed subgroup analyses based on the severity of psoriasis and psoriatic arthritis.
We included 169,909 psoriasis patients (including 13,959 with concomitant psoriatic arthritis and 155,950 with psoriasis alone) and 169,909 matched nonpsoriasis controls. Suicidal behavior occurred in 104 and 89 subjects in the psoriasis group and nonpsoriasis controls, respectively; we found no significantly increased risk for suicidal behavior among psoriasis patients when compared to nonpsoriasis controls [adjusted hazard ratio (HR) 1.17, 95% confidence interval (CI) 0.88‒1.55]. The subgroup analysis showed no significantly increased risk for suicidal behavior in both the severe psoriasis group (adjusted HR 0.92, 95% CI 0.51–1.64) and the mild psoriasis group (adjusted HR 1.26, 95% CI 0.91‒1.75) when compared to nonpsoriasis controls. Also, we found no significant increased risk for suicidal behavior in the group of psoriasis patients who also had psoriatic arthritis (adjusted HR 2.00, 95% CI 0.68‒5.85) and in the group of patients with psoriasis alone (adjusted HR 1.12, 95% CI 0.83‒1.50) when compared to nonpsoriasis controls.
In a Taiwanese setting, no link between psoriasis or psoriatic arthritis and suicidal behavior was detected.
We would like to thank the Sunflower Statistical Consulting Company, Kaohsiung, Taiwan for statistical advice.
Compliance with Ethical Standards
This study was supported by the Far Eastern Memorial Hospital, Taiwan (FEMH-2018-C-030).
Conflict of interest
Dr. Wang, Mr. Wang, Prof. Chi, Dr. Lin, Dr. Liao, Ms. Chen, and Dr. Tung declare no conflict of interest.
- 3.Chi CC, Wang J, Chen YF, Wang SH, Chen FL, Tung TH. Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: a nationwide population-based cohort study. J Dermatol Sci. 2015;78(3):232–8. https://doi.org/10.1016/j.jdermsci.2015.03.012.CrossRefPubMedGoogle Scholar
- 7.Damiani G, Franchi C, Pigatto P, Altomare A, Pacifico A, Petrou S, et al. Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new direct-acting antiviral agents. World J Hepatol. 2018;10(2):329–36. https://doi.org/10.4254/wjh.v10.i2.329.CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Santus P, Rizzi M, Radovanovic D, Airoldi A, Cristiano A, Conic R, et al. Psoriasis and respiratory comorbidities: the added value of fraction of exhaled nitric oxide as a new method to detect, evaluate, and monitor psoriatic systemic involvement and therapeutic efficacy. Biomed Res Int. 2018;2018:3140682. https://doi.org/10.1155/2018/3140682.CrossRefPubMedPubMedCentralGoogle Scholar
- 14.Malerba M, Damiani G, Radaeli A, Ragnoli B, Olivini A, Calzavara-Pinton PG. Narrowband ultraviolet B phototherapy in psoriasis reduces proinflammatory cytokine levels and improves vitiligo and neutrophilic asthma. Br J Dermatol. 2015;173(6):1544–5. https://doi.org/10.1111/bjd.13988.CrossRefPubMedGoogle Scholar
- 21.Koo J, Marangell LB, Nakamura M, Armstrong A, Jeon C, Bhutani T, et al. Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression. J Eur Acad Dermatol Venereol JEADV. 2017;31(12):1999–2009. https://doi.org/10.1111/jdv.14460.CrossRefPubMedGoogle Scholar
- 34.National Health Research Institutes. Longitudinal Health Insurance Databases. http://w3.nhri.org.tw/nhird/date_cohort.htm. Accessed 29 July 2015.
- 37.Wu JJ, Penfold RB, Primatesta P, Fox TK, Stewart C, Reddy SP, et al. The risk of depression, suicidal ideation and suicide attempt in patients with psoriasis, psoriatic arthritis or ankylosing spondylitis. J Eur Acad Dermatol Venereol JEADV. 2017;31(7):1168–75. https://doi.org/10.1111/jdv.14175.CrossRefPubMedGoogle Scholar
- 38.Gournellis R, Tournikioti K, Touloumi G, Thomadakis C, Michalopoulou PG, Michopoulos I, et al. Psychotic (delusional) depression and completed suicide: a systematic review and meta-analysis. Ann Gen Psychiatry. 2018;17:39. https://doi.org/10.1186/s12991-018-0207-1.CrossRefPubMedPubMedCentralGoogle Scholar
- 48.Korovesi A, Dalamaga M, Kotopouli M, Papadavid E. Adherence to the Mediterranean diet is independently associated with psoriasis risk, severity, and quality of life: a cross-sectional observational study. Int J Dermatol. 2019;58(9):e164–5. https://doi.org/10.1111/ijd.14523.CrossRefPubMedGoogle Scholar
- 49.Adawi M, Damiani G, Bragazzi NL, Bridgewood C, Pacifico A, Conic RRZ, et al. The impact of intermittent fasting (Ramadan fasting) on psoriatic arthritis disease activity, enthesitis, and dactylitis: a multicentre study. Nutrients. 2019;11(3):601. https://doi.org/10.3390/nu11030601.CrossRefPubMedCentralGoogle Scholar
- 50.Damiani G, Watad A, Bridgewood C, Pigatto PDM, Pacifico A, Malagoli P, et al. The impact of Ramadan fasting on the reduction of PASI score, in moderate-to-severe psoriatic patients: a real-life multicenter study. Nutrients. 2019;11(2):277. https://doi.org/10.3390/nu11020277.CrossRefPubMedCentralGoogle Scholar